No takes yet. Share an insight, caveat, or question.
Randomized trial reveals HMGB1's role in enhancing autophagy and drug resistance in leukemia, suggesting new therapeutic avenues.
Liu et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: